IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 774 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Next article
  Previous article 
  Table of Contents
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (199 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

In This Article

 Article Access Statistics
    PDF Downloaded96    
    Comments [Add]    

Recommend this journal


Year : 2010  |  Volume : 42  |  Issue : 2  |  Page : 116

Authors' reply

Government Medical College, Jagdalpur, Bastar, Chhattisgarh, India

Date of Web Publication23-Jun-2010

Correspondence Address:
Harminder Singh
Government Medical College, Jagdalpur, Bastar - 494 001, Chhattisgarh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 20711382

Rights and PermissionsRights and Permissions

How to cite this article:
Singh H, Dulhani N, Nel KB. Authors' reply. Indian J Pharmacol 2010;42:116

How to cite this URL:
Singh H, Dulhani N, Nel KB. Authors' reply. Indian J Pharmacol [serial online] 2010 [cited 2023 Mar 25];42:116. Available from: https://www.ijp-online.com/text.asp?2010/42/2/116/64492


This is with reference to the comments on our article. [1] The necessary clarifications are given as follows.

Hepatitis has been shown as an adverse drug reaction (ADR) to HAART, but some other studies do not report it commonly. We reported hepatotoxicity which includes hepatitis also. [2],[3] Out of 79 patients, 68 had at least one ADR (reported) and 11 patients had no ADR at all. A total of 120 ADRs were reported since some patients had multiple ADRs. Out of 137 patients, 15 died due to terminal AIDS, 9 were lost to follow up due to change in address, etc, 18 were excluded from the study, and 16 were non-compliant (stopped therapy) and non-adherent to the follow-up protocol. Most severe ADRs were anemia and hepatotoxicity. Severity grading was classified according to the Hartwig and Siegel scale. [4] The correlation of ADRs with age, sex and CD4 count was done. Further analysis of difference in average age and CD4 count among males and females, though helpful, should not undermine the scope and information provided by our study.

  References Top

1.Singh H, Dulhani N, Tiwari P, Singh P, Sinha T. A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh. Indian J Pharmacol 2009;41:224-6.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Balakrishnan K. Safety, tolerability and effectiveness of locally produced generic antiretroviral drugs in persons with HIV disease in Southern India. Int Cong Drug Ther HIV 2002;6:298.  Back to cited text no. 2      
3.Malangu NG. Self-Reported Adverse Effects as Barriers to Adherence to Antiretroviral Therapy in HIV-Infected Patients in Pretoria. SA FAM pract 2008;50:49.  Back to cited text no. 3      
4.Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:2229-32.  Back to cited text no. 4      


Print this article  Email this article


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow